TREM2 agonism vs antagonism in DAM microglia¶
Analysis ID: SDA-2026-04-01-gap-001
Question: The disease-associated microglia (DAM) phenotype involves TREM2 upregulation, but whether therapeutic agonism or antagonism of TREM2 is beneficial remains contested across disease stages.
Domain: neurodegeneration
Date: 2026-04-01
Debate Transcript Summary¶
This analysis used a 4-persona debate system:
- Theorist — Generates novel hypotheses
- Skeptic — Challenges assumptions and finds weaknesses
- Domain Expert — Assesses druggability and feasibility
- Synthesizer — Ranks hypotheses and extracts knowledge
Round 1: Theorist¶
[Dry run - no API key]
Round 2: Skeptic¶
[Dry run - no API key]
Round 3: Domain Expert¶
[Dry run - no API key]
Round 4: Synthesizer¶
[Dry run - no API key]
Generated by: SciDEX Atlas Layer
Platform: https://scidex.ai
This notebook is a reproducible artifact of multi-agent scientific debate.